{
    "statistics": {
        "address1": "333 Lakeside Drive",
        "city": "Foster City",
        "state": "CA",
        "zip": "94404",
        "country": "United States",
        "phone": "650 574 3000",
        "fax": "650 578 9264",
        "website": "https://www.gilead.com",
        "industry": "Drug Manufacturers - General",
        "industryKey": "drug-manufacturers-general",
        "industryDisp": "Drug Manufacturers - General",
        "sector": "Healthcare",
        "sectorKey": "healthcare",
        "sectorDisp": "Healthcare",
        "longBusinessSummary": "Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.",
        "fullTimeEmployees": 18000,
        "companyOfficers": [
            {
                "maxAge": 1,
                "name": "Mr. Daniel P.  O'Day",
                "age": 59,
                "title": "Chairman & CEO",
                "yearBorn": 1964,
                "fiscalYear": 2023,
                "totalPay": 6992634,
                "exercisedValue": 0,
                "unexercisedValue": 13201385
            },
            {
                "maxAge": 1,
                "name": "Mr. Andrew D. Dickinson",
                "age": 53,
                "title": "Chief Financial Officer",
                "yearBorn": 1970,
                "fiscalYear": 2023,
                "totalPay": 2664586,
                "exercisedValue": 0,
                "unexercisedValue": 5999063
            },
            {
                "maxAge": 1,
                "name": "Ms. Deborah H. Telman",
                "age": 58,
                "title": "Executive VP of Corporate Affairs, General Counsel & Corporate Secretary",
                "yearBorn": 1965,
                "fiscalYear": 2023,
                "totalPay": 2563013,
                "exercisedValue": 0,
                "unexercisedValue": 307810
            },
            {
                "maxAge": 1,
                "name": "Ms. Johanna  Mercier",
                "age": 53,
                "title": "Chief Commercial Officer",
                "yearBorn": 1970,
                "fiscalYear": 2023,
                "totalPay": 3096055,
                "exercisedValue": 0,
                "unexercisedValue": 5530527
            },
            {
                "maxAge": 1,
                "name": "Dr. Merdad V. Parsey M.D., Ph.D.",
                "age": 59,
                "title": "Chief Medical Officer",
                "yearBorn": 1964,
                "fiscalYear": 2023,
                "totalPay": 2792095,
                "exercisedValue": 0,
                "unexercisedValue": 4919564
            },
            {
                "maxAge": 1,
                "name": "Ms. Sandra  Patterson",
                "age": 56,
                "title": "Senior VP, Corporate Controller & Principal Accounting Officer",
                "yearBorn": 1967,
                "fiscalYear": 2023,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Ms. Jacquie  Ross C.F.A.",
                "title": "Vice President of Investor Relations",
                "fiscalYear": 2023,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Ms. Jyoti K. Mehra",
                "age": 47,
                "title": "Executive Vice President of Human Resources",
                "yearBorn": 1976,
                "fiscalYear": 2023,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Dr. Linda Slanec Higgins Ph.D.",
                "age": 61,
                "title": "Senior Vice President of Research, Innovation & Portfolio",
                "yearBorn": 1962,
                "fiscalYear": 2023,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Dr. Rudolf  Ertl",
                "age": 77,
                "title": "Senior Vice President of Commercial Operations of Australia, Canada, Europe",
                "yearBorn": 1946,
                "fiscalYear": 2023,
                "exercisedValue": 0,
                "unexercisedValue": 0
            }
        ],
        "auditRisk": 3,
        "boardRisk": 5,
        "compensationRisk": 4,
        "shareHolderRightsRisk": 1,
        "overallRisk": 2,
        "governanceEpochDate": 1714521600,
        "compensationAsOfEpochDate": 1703980800,
        "irWebsite": "http://investors.gilead.com/phoenix.zhtml?c=69964&p=irol-irhome",
        "maxAge": 86400,
        "priceHint": 2,
        "previousClose": 67.8,
        "open": 67.63,
        "dayLow": 66.01,
        "dayHigh": 67.63,
        "regularMarketPreviousClose": 67.8,
        "regularMarketOpen": 67.63,
        "regularMarketDayLow": 66.01,
        "regularMarketDayHigh": 67.63,
        "dividendRate": 3.08,
        "dividendYield": 0.0454,
        "exDividendDate": 1718323200,
        "payoutRatio": 8.3889,
        "fiveYearAvgDividendYield": 4.0,
        "beta": 0.235,
        "trailingPE": 183.80554,
        "forwardPE": 9.267507,
        "volume": 5596182,
        "regularMarketVolume": 5596182,
        "averageVolume": 6914401,
        "averageVolume10days": 5846180,
        "averageDailyVolume10Day": 5846180,
        "bid": 66.16,
        "ask": 66.2,
        "bidSize": 200,
        "askSize": 400,
        "marketCap": 82437890048,
        "fiftyTwoWeekLow": 64.33,
        "fiftyTwoWeekHigh": 87.87,
        "priceToSalesTrailing12Months": 3.003202,
        "fiftyDayAverage": 68.8256,
        "twoHundredDayAverage": 75.34495,
        "trailingAnnualDividendRate": 3.02,
        "trailingAnnualDividendYield": 0.04454277,
        "currency": "USD",
        "enterpriseValue": 103519846400,
        "profitMargins": 0.01767,
        "floatShares": 1243212000,
        "sharesOutstanding": 1245849984,
        "sharesShort": 21159970,
        "sharesShortPriorMonth": 22572691,
        "sharesShortPreviousMonthDate": 1711584000,
        "dateShortInterest": 1714435200,
        "sharesPercentSharesOut": 0.017,
        "heldPercentInsiders": 0.0010800001,
        "heldPercentInstitutions": 0.87934,
        "shortRatio": 2.97,
        "shortPercentOfFloat": 0.017,
        "impliedSharesOutstanding": 1245849984,
        "bookValue": 14.076,
        "priceToBook": 4.700909,
        "lastFiscalYearEnd": 1703980800,
        "nextFiscalYearEnd": 1735603200,
        "mostRecentQuarter": 1711843200,
        "netIncomeToCommon": 485000000,
        "trailingEps": 0.36,
        "forwardEps": 7.14,
        "pegRatio": 3.25,
        "lastSplitFactor": "2:1",
        "lastSplitDate": 1359331200,
        "enterpriseToRevenue": 3.771,
        "enterpriseToEbitda": 8.174,
        "52WeekChange": -0.12685126,
        "SandP52WeekChange": 0.27840328,
        "lastDividendValue": 0.77,
        "lastDividendDate": 1710374400,
        "exchange": "NMS",
        "quoteType": "EQUITY",
        "symbol": "GILD",
        "underlyingSymbol": "GILD",
        "shortName": "Gilead Sciences, Inc.",
        "longName": "Gilead Sciences, Inc.",
        "firstTradeDateEpochUtc": 696090600,
        "timeZoneFullName": "America/New_York",
        "timeZoneShortName": "EDT",
        "uuid": "8659e669-8ec5-3b0f-9929-db5db506231f",
        "messageBoardId": "finmb_29002",
        "gmtOffSetMilliseconds": -14400000,
        "currentPrice": 66.17,
        "targetHighPrice": 117.0,
        "targetLowPrice": 67.0,
        "targetMeanPrice": 81.29,
        "targetMedianPrice": 78.0,
        "recommendationMean": 2.5,
        "recommendationKey": "buy",
        "numberOfAnalystOpinions": 25,
        "totalCash": 6058999808,
        "totalCashPerShare": 4.863,
        "ebitda": 12664999936,
        "totalDebt": 25194000384,
        "quickRatio": 0.824,
        "currentRatio": 1.079,
        "totalRevenue": 27449999360,
        "debtToEquity": 144.337,
        "revenuePerShare": 22.0,
        "returnOnAssets": 0.10496,
        "returnOnEquity": 0.02391,
        "freeCashflow": 8886250496,
        "operatingCashflow": 8480999936,
        "revenueGrowth": 0.053,
        "grossMargins": 0.77523005,
        "ebitdaMargins": 0.46138,
        "operatingMargins": 0.3443,
        "financialCurrency": "USD",
        "trailingPegRatio": 0.842
    }
}